Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908943334> ?p ?o ?g. }
- W2908943334 endingPage "426" @default.
- W2908943334 startingPage "415" @default.
- W2908943334 abstract "Polycomb group proteins are important epigenetic regulators for cell proliferation and differentiation, organ development, as well as initiation and progression of lethal diseases, including cancer. Upregulated Polycomb group proteins, including Enhancer of zeste homolog 2 (EZH2), promote proliferation, migration, invasion and metastasis of cancer cells, as well as self‐renewal of cancer stem cells. In our study, we report that EZH2 and embryonic ectoderm development (EED) indicate respective direct interaction with androgen receptor (AR). In the context of AR‐positive prostate cancer, EZH2 and EED regulate AR expression levels and AR downstream targets. More importantly, we demonstrate that targeting EZH2 with the small‐molecule inhibitor astemizole in cancer significantly represses the EZH2 and AR expression as well as the neoplastic capacities. These results collectively suggest that pharmacologically targeting EZH2 might be a promising strategy for advanced prostate cancer." @default.
- W2908943334 created "2019-01-25" @default.
- W2908943334 creator A5003311852 @default.
- W2908943334 creator A5003465240 @default.
- W2908943334 creator A5003753200 @default.
- W2908943334 creator A5004208115 @default.
- W2908943334 creator A5006607922 @default.
- W2908943334 creator A5013607913 @default.
- W2908943334 creator A5023214008 @default.
- W2908943334 creator A5023457020 @default.
- W2908943334 creator A5027911071 @default.
- W2908943334 creator A5029992618 @default.
- W2908943334 creator A5036045846 @default.
- W2908943334 creator A5040561460 @default.
- W2908943334 creator A5046777605 @default.
- W2908943334 creator A5053367403 @default.
- W2908943334 creator A5054908983 @default.
- W2908943334 creator A5062873426 @default.
- W2908943334 creator A5070812231 @default.
- W2908943334 creator A5080970990 @default.
- W2908943334 creator A5088423634 @default.
- W2908943334 creator A5090606294 @default.
- W2908943334 date "2019-02-12" @default.
- W2908943334 modified "2023-10-14" @default.
- W2908943334 title "Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer" @default.
- W2908943334 cites W1973752700 @default.
- W2908943334 cites W1977090021 @default.
- W2908943334 cites W1985003152 @default.
- W2908943334 cites W2004380688 @default.
- W2908943334 cites W2008659365 @default.
- W2908943334 cites W2013149980 @default.
- W2908943334 cites W2017492512 @default.
- W2908943334 cites W2020230403 @default.
- W2908943334 cites W2024576630 @default.
- W2908943334 cites W2033478449 @default.
- W2908943334 cites W2048122601 @default.
- W2908943334 cites W2053116646 @default.
- W2908943334 cites W2055583066 @default.
- W2908943334 cites W2061846271 @default.
- W2908943334 cites W2075087486 @default.
- W2908943334 cites W2078980183 @default.
- W2908943334 cites W2079298594 @default.
- W2908943334 cites W2084295010 @default.
- W2908943334 cites W2089041551 @default.
- W2908943334 cites W2091098941 @default.
- W2908943334 cites W2097065948 @default.
- W2908943334 cites W2110241629 @default.
- W2908943334 cites W2113634596 @default.
- W2908943334 cites W2118428599 @default.
- W2908943334 cites W2120706598 @default.
- W2908943334 cites W2127684282 @default.
- W2908943334 cites W2130634531 @default.
- W2908943334 cites W2131836848 @default.
- W2908943334 cites W2132310381 @default.
- W2908943334 cites W2160689782 @default.
- W2908943334 cites W2163841147 @default.
- W2908943334 cites W2164052369 @default.
- W2908943334 cites W2166820820 @default.
- W2908943334 cites W2229833364 @default.
- W2908943334 cites W2320983896 @default.
- W2908943334 cites W2405233442 @default.
- W2908943334 cites W2582081516 @default.
- W2908943334 cites W2781525129 @default.
- W2908943334 cites W2783562181 @default.
- W2908943334 doi "https://doi.org/10.1002/ijc.32118" @default.
- W2908943334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7423571" @default.
- W2908943334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30628724" @default.
- W2908943334 hasPublicationYear "2019" @default.
- W2908943334 type Work @default.
- W2908943334 sameAs 2908943334 @default.
- W2908943334 citedByCount "47" @default.
- W2908943334 countsByYear W29089433342020 @default.
- W2908943334 countsByYear W29089433342021 @default.
- W2908943334 countsByYear W29089433342022 @default.
- W2908943334 countsByYear W29089433342023 @default.
- W2908943334 crossrefType "journal-article" @default.
- W2908943334 hasAuthorship W2908943334A5003311852 @default.
- W2908943334 hasAuthorship W2908943334A5003465240 @default.
- W2908943334 hasAuthorship W2908943334A5003753200 @default.
- W2908943334 hasAuthorship W2908943334A5004208115 @default.
- W2908943334 hasAuthorship W2908943334A5006607922 @default.
- W2908943334 hasAuthorship W2908943334A5013607913 @default.
- W2908943334 hasAuthorship W2908943334A5023214008 @default.
- W2908943334 hasAuthorship W2908943334A5023457020 @default.
- W2908943334 hasAuthorship W2908943334A5027911071 @default.
- W2908943334 hasAuthorship W2908943334A5029992618 @default.
- W2908943334 hasAuthorship W2908943334A5036045846 @default.
- W2908943334 hasAuthorship W2908943334A5040561460 @default.
- W2908943334 hasAuthorship W2908943334A5046777605 @default.
- W2908943334 hasAuthorship W2908943334A5053367403 @default.
- W2908943334 hasAuthorship W2908943334A5054908983 @default.
- W2908943334 hasAuthorship W2908943334A5062873426 @default.
- W2908943334 hasAuthorship W2908943334A5070812231 @default.
- W2908943334 hasAuthorship W2908943334A5080970990 @default.
- W2908943334 hasAuthorship W2908943334A5088423634 @default.
- W2908943334 hasAuthorship W2908943334A5090606294 @default.
- W2908943334 hasBestOaLocation W29089433341 @default.
- W2908943334 hasConcept C104317684 @default.